eletriptan
Sign in to saveAlso known as UK 116044
Eletriptan, sold under the brand name Relpax and used in the form of eletriptan hydrobromide, is a second-generation triptan medication intended for treatment of migraine headaches. It is used as an abortive medication, blocking a migraine attack which is already in progress. Eletriptan is marketed and manufactured by Pfizer.
Research
323 papers- Eletriptan.2006
- Eletriptan.Expert opinion on drug metabolism & toxicology · 2009
- Eletriptan.Expert opinion on investigational drugs · 2001
- Eletriptan.2026
- Eletriptan review.Expert opinion on pharmacotherapy · 2005
via PubMed
~8 min read
Encyclopedic overview
13 sectionsContents
- Medical uses
- Contraindications
- Side effects
- Interactions
- Pharmacology
- Mechanism of action
- Chemistry
- Additional chemical names
- History
- Society and culture
- Brand names
- References
- External links
{{Drugbox | Verifiedfields = verified | Watchedfields = verified | verifiedrevid = 459434734 | image = Eletriptan skeletal.svg | width = 250px | image_class = skin-invert-image | image2 = Eletriptan 3D ball-and-stick.png | image_class2 = bg-transparent | width2 = 250px
| tradename = Relpax, others | Drugs.com = | MedlinePlus = a603029 | DailyMedID = Eletriptan | pregnancy_AU = B1 | routes_of_administration = By mouth | class = Serotonin 5-HT1B, 5-HT1D, 5-HT1E, and 5-HT1F receptor agonist; Triptan; Antimigraine agent | ATC_prefix = N02 | ATC_suffix = CC06 | ATC_supplemental =
Excerpted from Wikipedia’s “eletriptan” article, available under the CC BY-SA 4.0 licence.
Available in 11 languages
via Wikidata sitelinks · CC0